{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:57Z","timestamp":1793814117760,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["SUBZ.A430.23.075"],"award-info":[{"award-number":["SUBZ.A430.23.075"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["SUBZ.A430.22.089"],"award-info":[{"award-number":["SUBZ.A430.22.089"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histopathological evaluation of lymph nodes in Merkel cell carcinoma has become crucial in progression estimation and treatment modification. This study was undertaken to determine the most sensitive immunohistochemical panel for detecting MCC nodal metastases. We included 56 patients with 102 metastatic MCC lymph nodes, which were tested with seven antibodies: cytokeratin (CKAE1\/AE3), CK20, chromogranin A, synaptophysin, INSM1, SATB2, and neurofilament (NF). Tissue microarrays (TMA) composed of 2-mm tissue cores from each nodal metastasis were constructed. A semiquantitative 5-tier scoring system (0%,\u2009&lt;\u200925%, 25\u201374%, 75\u201399%, 100% positive MCC cells with moderate to strong reactivity) was implemented. In the statistical assessment, we included Merkel cell polyomavirus (MCPyV) status and expression heterogeneity between lymph nodes from one patient. A cumulative percentage of moderate to strong expression\u2009\u2265\u200975% of tumoral cells was observed for single cell markers as follows: 91\/102 (89.2%) SATB2, 85\/102 (83%) CKAE1\/AE3, 80\/102 (78.4%) synaptophysin, 75\/102 (75.5%) INSM1, 68\/102 (66.7%) chromogranin A, 60\/102 cases (58.8%) CK20, and 0\/102 (0%) NF. Three markers presented a complete lack of immunoreactivity: 8\/102 (7.8%) CK20, 7\/102 (6.9%) chromogranin A, and 6\/102 (5.9%) NF. All markers showed expression heterogeneity in lymph nodes from one patient; however, the most homogenous was INSM1. The probability of detecting nodal MCC metastases was the highest while using SATB2 as a first-line marker (89.2%) with subsequential adding CKAE1\/AE3 (99%); these results were independent of MCPyV status. Synaptophysin showed a superior significance in confirming the neuroendocrine origin of metastatic cells. This comprehensive analysis allows us to recommend simultaneous evaluation of SATB2, CKAE1\/AE3, and synaptophysin in the routine pathologic MCC lymph node protocol.<\/jats:p>","DOI":"10.1007\/s00428-023-03691-7","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T22:01:21Z","timestamp":1702072881000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["SATB2, CKAE1\/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinoma"],"prefix":"10.1007","volume":"484","author":[{"given":"Anna","family":"Szumera-Cieckiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Massi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Cassisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Krzyzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dudzisz-Sledz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Biecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Marszalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8729-6216","authenticated-orcid":false,"given":"Piotr","family":"Donizy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"3691_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejca.2022.03.043","volume":"171","author":"ML Gauci","year":"2022","unstructured":"Gauci ML, Aristei C, Becker JC et al (2022) Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022. Eur J Cancer 171:203\u2013231","journal-title":"Eur J Cancer"},{"key":"3691_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jaad.2019.03.027","volume":"81","author":"RRZ Conic","year":"2019","unstructured":"Conic RRZ, Ko J, Saridakis S et al (2019) Sentinel lymph node biopsy in Merkel cell carcinoma: predictors of sentinel lymph node positivity and association with overall survival. J Am Acad Dermatol 81:364\u2013372","journal-title":"J Am Acad Dermatol"},{"key":"3691_CR3","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","volume":"23","author":"PJ Allen","year":"2005","unstructured":"Allen PJ, Bowne WB, Jaques DP et al (2005) Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300\u20132309","journal-title":"J Clin Oncol"},{"key":"3691_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.6004\/jnccn.2014.0123","volume":"12","author":"AS Moshiri","year":"2014","unstructured":"Moshiri AS, Nghiem P (2014) Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw 12:1255\u20131262","journal-title":"J Natl Compr Canc Netw"},{"key":"3691_CR5","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8","volume":"92","author":"PJ Allen","year":"2001","unstructured":"Allen PJ, Busam K, Hill AD (2001) Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 92:1650\u20131655","journal-title":"Cancer"},{"key":"3691_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1067\/mjd.2002.119563","volume":"46","author":"LD Su","year":"2002","unstructured":"Su LD, Lowe L, Bradford CR et al (2002) Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 46:661\u2013666","journal-title":"J Am Acad Dermatol"},{"key":"3691_CR7","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1096\/fj.08-125971","volume":"23","author":"MS Lan","year":"2009","unstructured":"Lan MS, Breslin MB (2009) Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J 23:2024\u20132033","journal-title":"FASEB J"},{"key":"3691_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/PAS.0000000000001037","volume":"42","author":"LM Rooper","year":"2018","unstructured":"Rooper LM, Bishop JA, Westra WH (2018) INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors. Am J Surg Pathol 42:665\u2013671","journal-title":"Am J Surg Pathol"},{"key":"3691_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/his.13943","volume":"76","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM (2020) SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathol 76:251\u2013264","journal-title":"Histopathol"},{"key":"3691_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/his.14012","volume":"76","author":"D Hoskoppal","year":"2020","unstructured":"Hoskoppal D, Epstein JI, Gownet AM et al (2020) SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Histopathol 76:550\u2013559","journal-title":"Histopathol"},{"key":"3691_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/PAS.0000000000001136","volume":"42","author":"MT Lilo","year":"2018","unstructured":"Lilo MT, Chen Y, LeBlanc RE (2018) INSM1 is more sensitive and interpretable than conventional immunohistochemical stains used to diagnose Merkel cell carcinoma. Am J Surg Pathol 42:1541\u20131548","journal-title":"Am J Surg Pathol"},{"key":"3691_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/ajcp\/aqaa017","volume":"154","author":"MP Hoang","year":"2020","unstructured":"Hoang MP, Donizy P, Wu CL et al (2020) TdT expression is a marker of better survival in Merkel cell carcinoma, and expression of B-cell markers is associated with Merkel cell polyomavirus. Am J Clin Pathol 154:38\u201347","journal-title":"Am J Clin Pathol"},{"key":"3691_CR13","unstructured":"R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2019. Available at: https:\/\/www.r-project.org\/. Accessed June, 22, 2022"},{"key":"3691_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) ggplot2: elegant graphics for data analysis. Springer-Verlag, New York"},{"key":"3691_CR15","first-page":"277","volume":"19","author":"M Mussini","year":"2018","unstructured":"Mussini M (2018) On measuring polarization for ordinal data: an approach based on the decomposition of the LetI Index. Stat Trans 19:277\u2013296","journal-title":"Stat Trans"},{"key":"3691_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jaad.2019.12.072","volume":"84","author":"AT Nguyen","year":"2021","unstructured":"Nguyen AT, Luu M, Lu DJ et al (2021) Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma. J Am Acad Dermatol 84:312\u2013320","journal-title":"J Am Acad Dermatol"},{"key":"3691_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","volume":"63","author":"BD Lemos","year":"2010","unstructured":"Lemos BD, Storer BE, Iyer JG et al (2010) Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 63:751\u2013761","journal-title":"J Am Acad Dermatol"},{"key":"3691_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archderm.142.6.685","volume":"142","author":"SG Gupta","year":"2006","unstructured":"Gupta SG, Wang LC, Pe\u00f1as PF et al (2006) Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142:685\u2013690","journal-title":"Arch Dermatol"},{"key":"3691_CR19","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1245\/s10434-012-2779-3","volume":"20","author":"JA Santamaria-Barria","year":"2013","unstructured":"Santamaria-Barria JA, Boland GM, Yeap BY et al (2013) Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol 20:1365\u20131373","journal-title":"Ann Surg Oncol"},{"key":"3691_CR20","unstructured":"Smoller BR, Bichakjian C, Brown JA et al (2022) Protocol for the examination of specimens from patients with Merkel cell carcinoma of the skin. June 2021, Version: 4.1.0.0. Available at: https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates. Accessed June, 14, 2022"},{"key":"3691_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gendis.2020.10.003","volume":"9","author":"X Huang","year":"2022","unstructured":"Huang X, Chen Q, Luoet W et al (2022) SATB2: A versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine. Genes Dis 9:95\u2013107","journal-title":"Genes Dis"},{"key":"3691_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41379-018-0155-y","volume":"32","author":"T Kervarrec","year":"2019","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E et al (2019) Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol 32:499\u2013510","journal-title":"Mod Pathol"},{"key":"3691_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00428-021-03255-7","volume":"480","author":"F Inzani","year":"2022","unstructured":"Inzani F, Angelico G, Santoro A et al (2022) SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix. Virchows Arch 480:873\u2013877","journal-title":"Virchows Arch"},{"key":"3691_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00403-016-1655-6","volume":"308","author":"M Fukuhara","year":"2016","unstructured":"Fukuhara M, Agnarsd\u00f3ttir M, Edqvistet PH et al (2016) SATB2 is expressed in Merkel cell carcinoma. Arch Dermatol Res 308:449\u2013454","journal-title":"Arch Dermatol Res"},{"key":"3691_CR25","first-page":"310","volume":"8","author":"K Jensen","year":"2000","unstructured":"Jensen K, Kohler S, Rouse RV (2000) Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5\/6, 7, 17, and 20. Appl Immunohistochem Mol Morphol 8:310\u2013315","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3691_CR26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/1097-0142(19860901)58:5<1040::AID-CNCR2820580511>3.0.CO;2-L","volume":"58","author":"H Battifora","year":"1986","unstructured":"Battifora H, Silva EG (1986) The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma. Cancer 58:1040\u20131046","journal-title":"Cancer"},{"key":"3691_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00000372-199902000-00003","volume":"21","author":"MP Scott","year":"1999","unstructured":"Scott MP, Helm KF (1999) Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 21:16\u201320","journal-title":"Am J Dermatopathol"},{"key":"3691_CR28","first-page":"384","volume":"8","author":"M Miettinen","year":"1995","unstructured":"Miettinen M (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8:384\u2013388","journal-title":"Mod Pathol"},{"key":"3691_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/(SICI)1097-0339(199812)19:6<472::AID-DC15>3.0.CO;2-K","volume":"19","author":"JF Legier","year":"1998","unstructured":"Legier JF (1998) Value of cytokeratin 20 stain in Merkel-cell carcinoma. Diagn Cytopathol 19:472","journal-title":"Diagn Cytopathol"},{"key":"3691_CR30","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.yexmp.2022.104762","volume":"126","author":"D Dum","year":"2022","unstructured":"Dum D, Menz A, V\u00f6lkel C et al (2022) Cytokeratin 7 and cytokeratin 20 expression in cancer: a tissue microarray study on 15,424 cancers. Exp Mol Pathol 126:104762","journal-title":"Exp Mol Pathol"},{"key":"3691_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41379-019-0394-6","volume":"33","author":"MT Tetzlaff","year":"2020","unstructured":"Tetzlaff MT, Harms PW (2020) Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma. Mod Pathol 33:42\u201355","journal-title":"Mod Pathol"},{"key":"3691_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J (2014) Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review. Diagn Pathol 9:221","journal-title":"Diagn Pathol"},{"key":"3691_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/s41379-019-0288-7","volume":"32","author":"T Kervarrec","year":"2019","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E et al (2019) Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma. Mod Pathol 32:1605\u20131616","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03691-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:57:04Z","timestamp":1714568224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03691-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3691"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03691-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as a retrospective study in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines, under the approval of the Ethics Committee of the Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland (No. 9\/2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}